VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,494,803 | -68.6% | 947,410 | -64.9% | 0.06% | -54.4% |
| Q2 2023 | $81,263,098 | +23.8% | 2,698,874 | +33.0% | 0.12% | +2.5% |
| Q1 2023 | $65,630,771 | +14.3% | 2,028,772 | +1.2% | 0.12% | -1.6% |
| Q4 2022 | $57,432,662 | +523.9% | 2,003,931 | +425.0% | 0.12% | +588.9% |
| Q3 2022 | $9,206,000 | +35.0% | 381,671 | +53.3% | 0.02% | +63.6% |
| Q2 2022 | $6,817,000 | -74.0% | 248,975 | -63.6% | 0.01% | -73.8% |
| Q1 2022 | $26,249,000 | -63.0% | 684,455 | -69.1% | 0.04% | -71.4% |
| Q4 2021 | $70,909,000 | -46.9% | 2,213,833 | -51.2% | 0.15% | -50.0% |
| Q3 2021 | $133,615,000 | -36.1% | 4,533,921 | -26.3% | 0.29% | -47.7% |
| Q2 2021 | $209,162,000 | +59.1% | 6,155,466 | +52.1% | 0.56% | +14.5% |
| Q1 2021 | $131,494,000 | +22.4% | 4,045,981 | +35.7% | 0.49% | +14.5% |
| Q4 2020 | $107,408,000 | +21.4% | 2,981,923 | +32.0% | 0.43% | +17.9% |
| Q3 2020 | $88,483,000 | -62.9% | 2,259,538 | -65.2% | 0.36% | -62.4% |
| Q2 2020 | $238,299,000 | +34.7% | 6,496,698 | -15.4% | 0.97% | +13.9% |
| Q1 2020 | $176,936,000 | -38.0% | 7,679,509 | -21.2% | 0.85% | -14.0% |
| Q4 2019 | $285,367,000 | -46.6% | 9,746,113 | -51.3% | 0.99% | -53.3% |
| Q3 2019 | $534,641,000 | +108.2% | 20,016,500 | +99.2% | 2.12% | +69.1% |
| Q2 2019 | $256,791,000 | +224.3% | 10,046,600 | +184.5% | 1.26% | +205.4% |
| Q1 2019 | $79,182,000 | +11.4% | 3,531,722 | +4.8% | 0.41% | -7.2% |
| Q4 2018 | $71,058,000 | +496.0% | 3,369,268 | +423.4% | 0.44% | +446.9% |
| Q3 2018 | $11,922,000 | -34.0% | 643,725 | -20.4% | 0.08% | -27.0% |
| Q2 2018 | $18,052,000 | +3.9% | 809,137 | +2.3% | 0.11% | -20.1% |
| Q1 2018 | $17,381,000 | -74.0% | 790,786 | -72.5% | 0.14% | -71.9% |
| Q4 2017 | $66,800,000 | -13.8% | 2,874,347 | -14.8% | 0.49% | -19.5% |
| Q3 2017 | $77,480,000 | -47.8% | 3,374,577 | -49.8% | 0.61% | -47.1% |
| Q2 2017 | $148,550,000 | +35.0% | 6,727,817 | +39.5% | 1.16% | +16.3% |
| Q1 2017 | $110,006,000 | +10.1% | 4,822,703 | +1.0% | 1.00% | +2.1% |
| Q4 2016 | $99,893,000 | -34.4% | 4,775,002 | -17.2% | 0.98% | -49.8% |
| Q3 2016 | $152,357,000 | +3.5% | 5,764,548 | +8.5% | 1.95% | -15.5% |
| Q2 2016 | $147,159,000 | – | 5,310,664 | – | 2.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |